Shikha Saini

Shikha Saini is a highly experienced scientist currently serving as a Senior Scientist at Bristol Myers Squibb since June 2023. Previously, Shikha held the position of Senior Scientist - Translational Biomarker Lead at Orum Therapeutics from July 2022 to March 2023. At Brigham and Women's Hospital, Shikha worked as a Research Scientist from April 2021 to July 2022 and as a Research Fellow from August 2019 to March 2022. Shikha's postdoctoral research was conducted at the University of Illinois at Chicago between April 2015 and July 2019, focusing on the mechanism of TRAIL resistance in anaplastic thyroid cancer. Earlier in Shikha's career, an experience as a Visiting Research Fellow at the National Institute of Immunology occurred from May 2014 to March 2015. Shikha earned a Ph.D. in Oncology and Cancer Biology from the National Institute of Immunology, New Delhi, India, and holds a Master's in Biotechnology from Guru Jambheshwar University of Science and Technology, as well as a Bachelor's in Biotechnology from Kurukshetra University.